Cancer treatment developers Ayala Pharmaceuticals and Advaxis to merge

Published on 19 Oct 2022 on American City Business Journals

Israel-based Ayala Pharmaceuticals, which has its U.S. headquarters in Wilmington, entered into a...

Read the rest of the article

Start tracking your investments with Statfolio

The firm set a “sell” rating on the stock. Ayala Pharmaceuticals Stock Performance Ayala...

ETF DAILY NEWS 9 Apr 2023

Analysts at StockNews.com began coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Get...

ETF DAILY NEWS 6 Apr 2023

Stock analysts at StockNews.com started coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS ...

ETF DAILY NEWS 5 Apr 2023

The firm set a “sell” rating on the stock. Ayala Pharmaceuticals Stock Performance Ayala ...

ETF DAILY NEWS 2 Apr 2023

The firm set a “sell” rating on the stock. Ayala Pharmaceuticals Stock Performance Ayala...

ETF DAILY NEWS 25 Mar 2023

Investment analysts at StockNews.com began coverage on shares of Ayala Pharmaceuticals (NASDAQ:AD...

ETF DAILY NEWS 24 Mar 2023

Investing.com 19 Oct 2022

Israel-based Ayala Pharmaceuticals, which has its U.S. headquarters in Wilmington, entered into a...

American City Business Journals 19 Oct 2022

Ayala Pharmaceuticals Inc (NASDAQ: AYLA) and Advaxis Inc (OTC: ADXS) have announced a merger agre...

Benzinga via Yahoo Finance 19 Oct 2022

Equities Research Analysts’ new coverage for Tuesday, May 3rd: StockNews.com began coverage on...

ETF DAILY NEWS 3 May 2022